300143 盈康生命
已收盘 06-12 15:00:00
资讯
新帖
简况
盈康生命旗下两医院入选帕金森病SPARK疗法全国合作医疗机构
证券之星 · 06-10
盈康生命旗下两医院入选帕金森病SPARK疗法全国合作医疗机构
盈康生命：回购股份不享有转增权利
证券之星 · 06-03
盈康生命：回购股份不享有转增权利
盈康生命旗下通达易入选合肥公共数据资源授权运营首批合伙人
证券之星 · 06-03
盈康生命旗下通达易入选合肥公共数据资源授权运营首批合伙人
股市必读：盈康生命（300143）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：盈康生命（300143）6月1日董秘有最新回复
盈康生命：截至2026年5月29日，公司股东总数为23,358户
证券之星 · 06-01
盈康生命：截至2026年5月29日，公司股东总数为23,358户
盈康生命：初步构建脑科学临床应用体系
证券之星 · 05-28
盈康生命：初步构建脑科学临床应用体系
盈康生命（300143）披露2025年度权益分派实施公告，5月28日股价上涨1.47%
证券之星 · 05-28
盈康生命（300143）披露2025年度权益分派实施公告，5月28日股价上涨1.47%
AI赋能“一核多元”筑牢肿瘤诊疗根基，盈康生命以“智护盈康”实现全周期守护
证券之星 · 05-12
AI赋能“一核多元”筑牢肿瘤诊疗根基，盈康生命以“智护盈康”实现全周期守护
股市必读：盈康生命（300143）5月8日董秘有最新回复
证券之星 · 05-11
股市必读：盈康生命（300143）5月8日董秘有最新回复
盈康生命：公司控股股东及实际控制人已通过资产注入、剥离及托管等方式解决同业竞争问题
证券之星 · 05-08
盈康生命：公司控股股东及实际控制人已通过资产注入、剥离及托管等方式解决同业竞争问题
业绩承诺超额兑现触发收购约定 盈康生命2.03亿元收购长沙珂信29%股权
证券之星 · 04-29
业绩承诺超额兑现触发收购约定 盈康生命2.03亿元收购长沙珂信29%股权
盈康生命(300143.SZ)发布一季度业绩，归母净利润2575.8万元，下降14.12%
智通财经 · 04-22
盈康生命(300143.SZ)发布一季度业绩，归母净利润2575.8万元，下降14.12%
股市必读：盈康生命(300143)股东户数2.89万户，较上期减少8.35%
证券之星 · 04-20
股市必读：盈康生命(300143)股东户数2.89万户，较上期减少8.35%
盈康生命：截至2026年4月10日，公司股东总数为28,943户
证券之星 · 04-17
盈康生命：截至2026年4月10日，公司股东总数为28,943户
股市必读：盈康生命（300143）4月8日披露最新机构调研信息
证券之星 · 04-09
股市必读：盈康生命（300143）4月8日披露最新机构调研信息
盈康生命：截至2026年3月31日，公司股东总数为31,581户
证券之星 · 04-07
盈康生命：截至2026年3月31日，公司股东总数为31,581户
股市必读：盈康生命(300143)股东户数2.5万户，较上期增加0.37%
证券之星 · 03-30
股市必读：盈康生命(300143)股东户数2.5万户，较上期增加0.37%
盈康生命(300143.SZ)发布2025年度业绩，归母净利润6854.07万元，下降40.62%
智通财经 · 03-27
盈康生命(300143.SZ)发布2025年度业绩，归母净利润6854.07万元，下降40.62%
盈康生命：公司目前暂无相关合作
证券之星 · 03-18
盈康生命：公司目前暂无相关合作
盈康生命：肿瘤全周期管理智能体
证券之星 · 03-09
盈康生命：肿瘤全周期管理智能体
加载更多
公司概况
公司名称：
盈康生命科技股份有限公司
所属行业：
卫生
上市日期：
2010-12-09
主营业务：
盈康生命科技股份有限公司的主营业务是提供以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司的主要产品是医疗设备及耗材产品。
发行价格：
36.00
{"stockData":{"symbol":"300143","market":"SZ","secType":"STK","nameCN":"盈康生命","latestPrice":6.99,"timestamp":1781247789000,"preClose":6.83,"halted":0,"volume":6551380,"delay":0,"changeRate":0.0234,"floatShares":834000000,"shares":973000000,"eps":0.0661,"marketStatus":"已收盘","change":0.16,"latestTime":"06-12 15:00:00","open":6.93,"high":7.05,"low":6.84,"amount":45738100,"amplitude":0.0307,"askPrice":6.99,"askSize":63,"bidPrice":6.98,"bidSize":1162,"shortable":0,"etf":0,"ttmEps":0.0661,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":6.83,"symbolType":"stock","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":7.51,"lowLimit":6.15,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":972931746,"isCdr":false,"pbRate":2.61,"roa":"--","peRate":105.748865,"roe":"1.02%","epsLYR":0.09,"committee":-0.161614,"marketValue":6801000000,"turnoverRate":0.0079,"status":0,"floatMarketCap":5827000000},"requestUrl":"/m/hq/s/300143","defaultTab":"news","newsList":[{"id":"2642744142","title":"盈康生命旗下两医院入选帕金森病SPARK疗法全国合作医疗机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2642744142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642744142?lang=zh_cn&edition=full","pubTime":"2026-06-10 16:53","pubTimestamp":1781081597,"startTime":"0","endTime":"0","summary":"2026年5月，银河脑科学公布了最新的帕金森病SPARK(SCAN-Parkinson‘s)环路个体精准调控全国合作医疗机构名单，盈康生命旗下四川友谊医院、青岛盈海医院位列其中。2025年底，四川友谊医院即引入个体脑功能剖分(pBFS)技术，并于2026年3月正式挂牌“刘河生教授脑疾病精准诊疗技术(pBFS)西南临床应用基地”，成为西南地区率先引入该技术的医疗机构。此后，医院已围绕帕金森病、阿尔茨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026061000029697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904006","title":"盈康生命：回购股份不享有转增权利","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640904006?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:53","pubTimestamp":1780491202,"startTime":"0","endTime":"0","summary":"根据《公司法》及《深圳证券交易所上市公司自律监管指引第9号——回购股份》等规定，上市公司回购专用账户中的股份，不享有股东会表决权、利润分配、公积金转增股本、认购新股和可转换公司债券等权利，不得质押和出借。投资者持有的有限售条件流通股与无限售条件流通股，均属于股东持有的权益性证券，同等参与本次转增与分红。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300044519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640497926","title":"盈康生命旗下通达易入选合肥公共数据资源授权运营首批合伙人","url":"https://stock-news.laohu8.com/highlight/detail?id=2640497926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640497926?lang=zh_cn&edition=full","pubTime":"2026-06-03 14:53","pubTimestamp":1780469633,"startTime":"0","endTime":"0","summary":"近日，合肥市大数据资产运营有限公司正式公布公共数据资源授权运营首批合伙人名单。盈康生命控股子公司——盈康一生通达易(厦门)信息科技有限公司凭借在健康医疗大数据领域的技术实力与丰富实践，成功入选首批合伙人名单，成为合肥市公共数据资源授权运营的重要生态伙伴。此次通达易入选合肥市公共数据资源授权运营首批合伙人，不仅是对公司技术能力与合规治理水平的认可，也为公司在更广泛区域参与公共数据运营奠定了示范基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026060300025467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640690809","title":"股市必读：盈康生命（300143）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640690809?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:56","pubTimestamp":1780340170,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，盈康生命报收于10.29元，上涨1.28%，换手率0.64%，成交量4.1万手，成交额4215.39万元。董秘最新回复投资者： 请问截至5月29日公司股东人数多少？截至2026年5月29日，公司股东总数为23,358户。当日关注点来自交易信息汇总：6月1日主力资金净流入38.74万元，显示主力对盈康生命短期走势持相对积极态度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640958440","title":"盈康生命：截至2026年5月29日，公司股东总数为23,358户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640958440?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:09","pubTimestamp":1780308552,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至5月29日公司股东人数多少？谢谢盈康生命回复：尊敬的投资者，您好！截至2026年5月29日，公司股东总数为23,358户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638695158","title":"盈康生命：初步构建脑科学临床应用体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2638695158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638695158?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:52","pubTimestamp":1779972757,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命05月28日在投资者关系平台上答复投资者关心的问题。在脑机接口和AI医疗双赛道持续升温的背景下，公司作为创业板中稀缺的脑科学+AI医疗临床应用标的，未来在脑科学、AI智能体等领域是否有进一步规划？在脑科学领域，公司围绕帕金森、阿尔茨海默病、焦虑症、脑梗后遗症、孤独症五大病种，初步构建覆盖“全生命周期、多学科协作、个性化诊疗”的脑科学临床应用体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800041227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638661160","title":"盈康生命（300143）披露2025年度权益分派实施公告，5月28日股价上涨1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638661160","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638661160?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:42","pubTimestamp":1779961331,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，盈康生命报收于10.33元，较前一交易日上涨1.47%，最新总市值为77.42亿元。该股当日开盘10.2元，最高10.38元，最低10.1元，成交额达5542.57万元，换手率为0.84%。近日，盈康生命科技股份有限公司发布《2025年度权益分派实施公告》。股权登记日为2026年6月2日，除权除息日为2026年6月3日。本次权益分派对象为截至股权登记日在中国结算深圳分公司登记在册的全体股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800031955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634952250","title":"AI赋能“一核多元”筑牢肿瘤诊疗根基，盈康生命以“智护盈康”实现全周期守护","url":"https://stock-news.laohu8.com/highlight/detail?id=2634952250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634952250?lang=zh_cn&edition=full","pubTime":"2026-05-12 10:46","pubTimestamp":1778553972,"startTime":"0","endTime":"0","summary":"用AI补齐院外管理短板，实现全周期服务闭环。智护盈康 APP 的正式上线，与 “一核多元” 肿瘤微创综合诊疗服务体系形成深度协同，是盈康生命从医疗服务与医疗器械双轮驱动的综合性医疗集团，向 AI 赋能主动健康科技平台战略转型的关键一步，也是公司 “让科技有温度，让守护更可及” 理念的具象化落地。目前，“一核多元” 诊疗体系已成为旗下医院的核心特色优势，智护盈康 APP 也已进入旗下医院内部推广阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2026051200013718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634426305","title":"股市必读：盈康生命（300143）5月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2634426305","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634426305?lang=zh_cn&edition=full","pubTime":"2026-05-11 02:52","pubTimestamp":1778439130,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，盈康生命报收于11.36元，上涨0.71%，换手率1.33%，成交量8.51万手，成交额9685.17万元。截至2026年4月30日，公司股东总数为26,038户。公司控股股东及实际控制人已通过资产注入、剥离及托管等方式解决同业竞争问题。您所述的传言不属实，盈康生命作为一家规范运作的上市公司，旗下医院均严格依法依规开展医疗服务，从未开展或参与相关业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633487433","title":"盈康生命：公司控股股东及实际控制人已通过资产注入、剥离及托管等方式解决同业竞争问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2633487433","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633487433?lang=zh_cn&edition=full","pubTime":"2026-05-08 15:09","pubTimestamp":1778224154,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问：海尔集团的旗下跟盈康生命同业竞争的业务板块为什么不置入盈康生命？盈康生命回复：尊敬的投资者，您好！公司控股股东及实际控制人已通过资产注入、剥离及托管等方式解决同业竞争问题。具体可详见公司在巨潮资讯网（http://www.cninfo.com.cn）披露的《2025年年度报告》。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800021291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631516816","title":"业绩承诺超额兑现触发收购约定 盈康生命2.03亿元收购长沙珂信29%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2631516816","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631516816?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:53","pubTimestamp":1777463586,"startTime":"0","endTime":"0","summary":"4月29日，盈康生命发布公告，拟以支付现金20,300万元方式收购公司控股子公司长沙珂信肿瘤医院有限公司29%股权。完成业绩承诺触发收购条款对于此次收购，公告提到，公司对长沙珂信的持股比例将进一步提升，有助于公司围绕以肿瘤为代表的高质量学科生态，持续深化区域医疗中心战略布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026042900060957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629302385","title":"盈康生命(300143.SZ)发布一季度业绩，归母净利润2575.8万元，下降14.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629302385","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629302385?lang=zh_cn&edition=full","pubTime":"2026-04-22 23:13","pubTimestamp":1776870816,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盈康生命(300143.SZ)发布2026年第一季度报告，该公司营业收入为4.96亿元，同比增长21.36%。归属于上市公司股东的净利润为2575.8万元，同比减少14.12%。归属于上市公司股东的扣除非经常性损益的净利润为2398.58万元，同比减少19.95%。基本每股收益为0.0346元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628279593","title":"股市必读：盈康生命(300143)股东户数2.89万户，较上期减少8.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628279593","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628279593?lang=zh_cn&edition=full","pubTime":"2026-04-20 04:02","pubTimestamp":1776628934,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，盈康生命报收于12.07元，下跌2.11%，换手率2.15%，成交量13.76万手，成交额1.65亿元。来自股本股东变化：截至4月10日股东户数环比减少8.35%，户均持股上升至2.59万股，筹码集中度提升。股本股东变化股东户数变动近日盈康生命披露，截至2026年4月10日公司股东户数为2.89万户，较3月31日减少2638.0户，减幅为8.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628219212","title":"盈康生命：截至2026年4月10日，公司股东总数为28,943户","url":"https://stock-news.laohu8.com/highlight/detail?id=2628219212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628219212?lang=zh_cn&edition=full","pubTime":"2026-04-17 11:33","pubTimestamp":1776396796,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)04月17日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新的股东户数盈康生命回复：尊敬的投资者，您好！截至2026年4月10日，公司股东总数为28,943户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700019927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626558929","title":"股市必读：盈康生命（300143）4月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2626558929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626558929?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:45","pubTimestamp":1775670315,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，盈康生命报收于12.78元，上涨3.48%，换手率3.77%，成交量24.2万手，成交额3.06亿元。当日关注点来自交易信息汇总：4月8日主力资金净流出156.99万元，散户资金净流入230.54万元。2025年度实现净利润6,084.78万元，完成业绩承诺，无需业绩补偿。截至2025年度报告披露日，已运用相关技术治疗患者20人次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625131989","title":"盈康生命：截至2026年3月31日，公司股东总数为31,581户","url":"https://stock-news.laohu8.com/highlight/detail?id=2625131989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625131989?lang=zh_cn&edition=full","pubTime":"2026-04-07 11:30","pubTimestamp":1775532639,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)04月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司3月31日股东人数，谢谢盈康生命回复：尊敬的投资者，您好！截至2026年3月31日，公司股东总数为31,581户。如您有进一步查询需求，根据监管机构及《公司章程》的相关规定，可向公司提供证明持有公司股份的种类以及持股数量的书面文件，公司经核实股东身份后按照股东的要求予以提供。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700012247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623357768","title":"股市必读：盈康生命(300143)股东户数2.5万户，较上期增加0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623357768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623357768?lang=zh_cn&edition=full","pubTime":"2026-03-30 02:50","pubTimestamp":1774810218,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，盈康生命报收于12.53元，上涨1.13%，换手率4.25%，成交量27.28万手，成交额3.4亿元。股本股东变化股东户数变动截至2026年2月27日公司股东户数为2.5万户，较2月13日增加93.0户，增幅0.37%。该项计提减少2025年度利润总额2,458.74万元，减少归属于上市公司所有者权益2,300.64万元。盈康生命科技股份有限公司2025年度募集资金存放与使用情况鉴证报告2020年募集资金截至2025年末余额16,429,586.76元；2022年募集资金专户余额为0.00元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828224","title":"盈康生命(300143.SZ)发布2025年度业绩，归母净利润6854.07万元，下降40.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828224","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622828224?lang=zh_cn&edition=full","pubTime":"2026-03-27 18:49","pubTimestamp":1774608557,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盈康生命(300143.SZ)发布2025年年度报告，该公司营业收入为18.86亿元，同比增长20.93%。归属于上市公司股东的净利润为6854.07万元，同比减少40.62%。归属于上市公司股东的扣除非经常性损益的净利润为1.07亿元，同比增长28.50%。基本每股收益为0.09元。此外，拟向全体股东每10股派发现金红利0.25元(含税)，送红股0股(含税)，以资本公积金向全体股东每10股转增3股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"盈康生命(300143.SZ)发布2025年度业绩，归母净利润6854.07万元，下降40.62%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620289132","title":"盈康生命：公司目前暂无相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2620289132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620289132?lang=zh_cn&edition=full","pubTime":"2026-03-18 12:42","pubTimestamp":1773808932,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，注意到公司在布局AI制药相关方面，也注意到公司在和泓博医药有AI制药AI大模型相关的合作，泓博医药可以说是国内AI制药第一股，现在市值这么低潜力这么巨大，公司为什么不直接控股或者收购呢盈康生命回复：尊敬的投资者，您好！经核实，公司目前暂无相关合作，敬请投资者注意投资风险。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800019067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618626737","title":"盈康生命：肿瘤全周期管理智能体","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618626737?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:51","pubTimestamp":1773060681,"startTime":"0","endTime":"0","summary":"盈康生命发布了肿瘤场景智能体规划。这是一款围绕肿瘤场景打造的、面向患者端的智能体，旨在让每个肿瘤患者拥有自己的私人医生，是盈康生命肿瘤战略承接的一款核心产品。同时，公司联合联影智能、蚂蚁健康、惠美科技等生态伙伴，共同启动了“AI肿瘤全周期管理生态平台”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900032611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781389255716,"stockEarnings":[{"period":"1week","weight":-0.0692},{"period":"1month","weight":-0.2006},{"period":"3month","weight":-0.3201},{"period":"6month","weight":-0.0773},{"period":"1year","weight":-0.0793},{"period":"ytd","weight":-0.0793}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"盈康生命科技股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"23358人(较上一季度减少10.29%)","perCapita":"35689股","listingDate":"2010-12-09","address":"山东省青岛市城阳区春阳路37号","registeredCapital":"97293万元","survey":" 盈康生命科技股份有限公司的主营业务是提供以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司的主要产品是医疗设备及耗材产品。","listedPrice":36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盈康生命,300143,盈康生命股票,盈康生命股票老虎,盈康生命股票老虎国际,盈康生命行情,盈康生命股票行情,盈康生命股价,盈康生命股市,盈康生命股票价格,盈康生命股票交易,盈康生命股票购买,盈康生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}